Midwest Trust’s Quest Diagnostics DGX Stock Holding History

Midwest Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.7M	Sell	95,200 -300	-0.3%	-$58.3K	0.23%	106
2025 Q4	$16.6M	Buy	95,500 +927	+1%	+$169K	0.21%	111
2025 Q3	$18M	Sell	94,573 -5,691	-6%	-$1.01M	0.23%	104
2025 Q2	$18M	Buy	+100,264	New	+$17.4M	0.25%	102

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Midwest Trust's DGX Position: Q1 2026 in Review

Midwest Trust reduced its Quest Diagnostics (DGX) stake by 0.31% in Q1 2026, selling an estimated $58.3K and leaving 95,200 shares worth $18.7M. The position accounts for 0.23% of the portfolio, ranked #106.

Midwest Trust first reported a position in DGX in Q2 2025 and has held it in 4 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Midwest Trust held 95,200 shares of Quest Diagnostics worth $18.7M as of Q1 2026.
Midwest Trust sold 300 Quest Diagnostics shares in Q1 2026, an estimated $58.3K.
Quest Diagnostics made up 0.23% of Midwest Trust's portfolio in Q1 2026, its #106 holding.
Midwest Trust first reported a position in Quest Diagnostics in Q2 2025 and has held it in 4 quarters since.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.